Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy

Conclusion: CD64-NVs are charismatic carriers to achieve both checkpoint blockade and immunomodulatory drugs for combined cancer immunotherapy.

Source: Theranostics - April 19, 2021 Category: Molecular Biology Authors: Liyan Li, Qianwei Miao, Fanqiang Meng, Baoqi Li, Tianyuan Xue, Tianliang Fang, Zhirang Zhang, Jinxie Zhang, Xinyu Ye, Yang Kang, Xingding Zhang, Qian Chen, Xin Liang, Hongbo Chen, Xudong Zhang Tags: Research Paper Source Type: research